Aspirin unneeded with anticoagulation/clopidogrel after MI, PCI in AF; vegetarian diet linked to longer life; FDA: Rosiglitazone does not up CV risk; New obesity drug, lorcaserin
(Source: Radio TheHeart.org)
Source: Radio TheHeart.org - June 14, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
Aspirin Associated with Reduced Melanoma Risk
(Source: MedlinePlus: NLM Director's Comments)
Source: MedlinePlus: NLM Director's Comments - April 1, 2013 Category: Databases & Libraries Authors: National Library of Medicine Source Type: podcasts
What Is the Key to Aspirin's Benefit in CRC?
Why does aspirin increase survival only in some colon cancer patients? Dr. David Kerr reports on a study suggesting a PIK3CA mutation may be a predictive marker for use of aspirin as adjuvant therapy. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - March 20, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
Secondary Stroke Prevention: Are 2 Meds Better Than 1?
Dr. Hans-Christoph Diener discusses CHANCE, a trial comparing aspirin therapy with aspirin plus clopidogrel in patients with acute TIAs or minor stroke. (Source: Medscape Neurology Podcast)
Source: Medscape Neurology Podcast - March 7, 2013 Category: Neurology Authors: Medscape Source Type: podcasts
Secondary Stroke Prevention: Are 2 Meds Better Than 1?
Dr. Hans-Christoph Diener discusses CHANCE, a trial comparing aspirin therapy with aspirin plus clopidogrel in patients with acute TIAs or minor stroke. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - March 7, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
#178: Short course of aspirin, clopidogrel cuts stroke risk; Lp(a) gene variant associated with aortic stenosis; MAGELLAN published: Rivaroxaban reduces VTE risk in acutely ill patients; weight-loss drug Qsymia improves cardiovascular risk profile
course of aspirin, clopidogrel cuts stroke risk; Lp(a) gene variant associated with aortic stenosis; MAGELLAN published: Rivaroxaban reduces VTE risk in acutely ill patients; weight-loss drug Qsymia improves cardiovascular risk profile (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - February 15, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
Role of aspirin and NSAIDS in the Adjuvant Therapy of Colon Cancer
John Marshall talks about the role of aspirin and NSAIDS in the Adjuvant Therapy of Colon Cancer
Author: imedex
Added: 02/04/2013 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2013 Category: Cancer & Oncology Source Type: podcasts
Good for Celebrants, Better for Colon Cancer Patients
Dr. John Marshall discusses a study that found regular aspirin use to increase survival in CRC patients, especially those with PIK3CA mutation. But should all CRC patients take it, and at what dose? (Source: Medscape Oncology)
Source: Medscape Oncology - January 10, 2013 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Good for Celebrants, Better for Colon Cancer Patients
Dr. John Marshall discusses a study that found regular aspirin use to increase survival in CRC patients, especially those with PIK3CA mutation. But should all CRC patients take it, and at what dose? (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - January 10, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
#156: Results from ESC 2012; TRILOGY ACS: No win for prasugrel; WOEST: Drop aspirin in stent patients on oral anticoagulants; ALTITUDE: New data on why trial halted; PARAMOUNT phase 2; IABP SHOCK II; New European STEMI guidelines; HPS2-THRIVE
Results from ESC 2012; TRILOGY ACS: No win for prasugrel; WOEST: Drop aspirin in stent patients on oral anticoagulants; ALTITUDE: New data on why trial halted; PARAMOUNT phase 2: Agent shows promise in preserved-EF HF; IABP SHOCK II: No survival benefit o (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - August 31, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#144: Exercise worsens a CV risk factor in 10% of people; don't give up on HDL, researchers plead; major bleeding with aspirin in primary prevention underestimated; dietary calcium better than supplements; more evidence dark chocolate is cardioprotective
Exercise worsens a CV risk factor in 10% of people; don't give up on HDL, researchers plead; major bleeding with aspirin in primary prevention underestimated; dietary calcium better than supplements; more evidence dark chocolate is cardioprotective (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - June 8, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
The Lancet: March 23, 2012
Andrew Chan assesses new research about aspirin and cancer prevention. (Source: Listen to The Lancet)
Source: Listen to The Lancet - March 23, 2012 Category: General Medicine Authors: The Lancet Source Type: podcasts
